EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$12.27
+2.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 106.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.60x
- Price / sales
- 44.53x
- Price / cash flow
- -6.01x
Enterprise value
- Enterprise value
- $252.6M
- EV / sales
- 25.26x
- EV / EBITDA
- -2.64x
- EV / EBIT
- -2.48x
- Market cap
- $445.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026